Aratana Therapeutics Inc.

(PETX) Trade

By |

Profile

Aratana Therapeutics Inc is a pet therapeutics company. Its main activity is the licensing, developing, and commercializing of innovative biopharmaceutical products for companion animals. The company's portfolio consists of therapeutic candidates such as small-molecule pharmaceuticals and large-molecule biologics. The main product candidates in development comprise small-molecule pharmaceuticals directed at treating osteoarthritis pain, inflammation, appetite stimulation, and post-operative pain. The firm's strategy consists of licensing proprietary technology from human biopharmaceutical companies or academia to develop therapeutics specifically for use in pets.

Contact Information

Website: www.aratana.com
Email: ctooman@aratana.com
Main Phone: +1 913 353-1000
Address: 11400 Tomahawk Creek Parkway
Address 2: Suite 340
State: KS
City / Town: Leawood
Country: USA
Postal Code: 66211

Issuer Information

Exchange: NSD
CEO: Steven St. Peter
Employees: 88
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Aratana Therapeutics Inc is a pet therapeutics company. Its main activity is the licensing, developing, and commercializing of innovative biopharmaceutical products for companion animals. The company's portfolio consists of therapeutic candidates such as small-molecule pharmaceuticals and large-molecule biologics. The main product candidates in development comprise small-molecule pharmaceuticals directed at treating osteoarthritis pain, inflammation, appetite stimulation, and post-operative pain. The firm's strategy consists of licensing proprietary technology from human biopharmaceutical companies or academia to develop therapeutics specifically for use in pets.

Contact Information

Website: www.aratana.com
Email: ctooman@aratana.com
Main Phone: +1 913 353-1000
Address: 11400 Tomahawk Creek Parkway
Address 2: Suite 340
State: KS
City / Town: Leawood
Country: USA
Postal Code: 66211

Issuer Information

Exchange: NSD
CEO: Steven St. Peter
Employees: 88
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 4.37 $ -0.05 (-1.13%)
Last Price 4.37 Change $ -0.05 Change % -1.13 Tick N/A
Bid 4.39 Bid Size 5,000.00 Ask 4.48 Ask Size 500.00
Open 4.42 High 4.59 Low 4.34 Prev Close 4.42
Last Trade Volume 829,390 52 Wk Hi 7.16 52 Wk Low 3.67
Market Cap 212.5 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 48,624,202.00 EPS (TTM) -0.51 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 1 40
Number of Buys 0 14
Number of Sells 1 26
Net Activity -11513 -752029
Last 10 Buys Shares
Ansbert Gadicke 1,000
John Vander Vort 1,000
St Steven Peter 1,000
Julia A. Stephanus 1,000
Jay Lichter 1,000
Last 10 Sell Shares
St Steven Peter 1,000
St Steven Peter 1,000
Craig A. Tooman 1,000
Kevin Kotler 1,000
Kevin Kotler 1,000
Kevin Kotler 1,000
Kevin Kotler 1,000
Kevin Kotler 1,000
Kevin Kotler 1,000
Kevin Kotler 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 10 10 10 10
Low Target Price Estimate 7 7 7 7
Mean Target Price Estimate 8.75 8.75 8.7 8.75
Standard Deviation 1.5 1.5 1.3 1.5
Date of Most Recent Estimate 05/06/18 05/06/18 05/06/18 05/06/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 5 5 4
Moderate Buy 1 1 1 1
Hold 0 0 0 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.2 1.17 1.17 1.5